Check out what we have in store for you in the October Newsletter

Dear Advocaters,

Halloween is almost here and we have some informative but scary articles in this month’s HCV Advocate newsletter:

• • HealthWise – Jailed for Hepatitis C – by Lucinda Porter, RN is an informative article about making hepatitis C a crime.  In fact, in some states, it already is a crime.   
    “It used to be that having hepatitis C would land you in the doctor’s office. Never in my wildest dreams did I imagine that it could land me in jail. However, theoretically it could.”

  • Hepatitis Headlines – The drug epidemic and how Russian hackers are trying to mess with our health.
  • Hep C 101 – Nail Care Settings by Alan Franciscus – in this month’s column I discuss safety measures to look for when going to a nail salon or beauty parlor.
  • SnapShots by Alan Franciscus has the following recap on abstracts:
    1. Proton pump inhibitors and risk of hepatocellular carcinoma in
       patients with chronic hepatitis B or C—W. Kao, et. al
    2. Lack of patient compliance in real-world practice negatively affects sustained viral response rates to direct-acting agent therapy for hepatitis C –M. C. Marshall, et. al.

         BRIEFLY …

    1. Inovio (INO) initiates phase 1 study on hepatitis C vaccine – Zacks Equity Research
    2. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia
    3. Cardiac transplantation from non-viremic hepatitis C donors
    4. Cost-effectiveness of transplanting HCV-infected livers into uninfected recipients with preemptive antiviral therapy

 

• • What’s Up – We have updated the following Extrahepatic Manifestation Fact Sheets:
    • Essential Cryoglobulinemic Vasculitis
    • Porphyria Cutanea Tarda
    • Non-Hodgkin’s Lymphoma
    • Pruritus
    • Overview of Extrahepatic Manifestations

 

• Watch our patient video about treating and curing HCV.
• Do you have hepatitis C?  Get support.  Get answers.  A free program for patients – PackHealth.

To Your Health and Prosperity,

Alan and the team of the HCV Advocate

Share This Page
Follow Us

Check out what we have in store for you in the September Newsletter

In this month’s HCV Advocate newsletter, the following noteworthy articles are available to read and educate:

• SnapShots by Alan Franciscus
  • Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes—A. Rawshani, et. al.
  • Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs—P. Nahom, et. al.
  • Safety and efficacy of ledipasvir‐sofosbuvir with or without ribavirin for chronic hepatitis C in children ages 6‐11—K. F. Murry, et. al
  • Briefly……..
    • Commentary: A review of the risk of hepatitis B and C transmission through biting or spitting—H. Pintilie, et. al.
    • Hepatitis C virus infection in children in the era of direct-acting antivirals—M. Pawlowska, et. al
• HealthWise – A Buffet of Health Information – as the title of the article implies, Lucinda discusses the various substances that may or may not be good for your health.
• Hepatitis Headlines – Three interesting news stories about hepatitis C that our readers will find interesting including heart transplants, eliminating hepatitis in the U.S. and WHO and HCV treatment guidelines.
• Hep C 101 – Overview of Hepatitis C by Alan Franciscus – A new series of article for people who are new to hepatitis C or for those people who want basic information.
• What’s Up – We’ve updated several of the HCV Advocate Factsheets. Use the links provided in this section to get current information on several subjects that relate to Hep C, including nutrition, alcohol, co-infection, and motherhood.

• Watch our patient video about treating and curing HCV.
• Do you have hepatitis C?  Get support.  Get answers.  A free program for patients – PackHealth.

To Your Health,

Alan and the team of the HCV Advocate

Share This Page
Follow Us